FDA
approval
· 2019-03-11
FDA Approved: NIKKI — Supplemental Application (Lupin Pharmaceuticals, Inc.)
Summary
FDA approved Lupin Pharmaceuticals' supplemental application for NIKKI, a generic drospirenone/ethinyl estradiol combination oral contraceptive. The approval re…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NIKKI (DROSPIRENONE AND ETHINYL ESTRADIOL)